Chicago Partners Investment Group
NRXP icon

Chicago Partners Investment Group’s NRX Pharmaceuticals NRXP Stock Holding History

Chicago Partners Investment Group’s Portfolio NRXP Stock Details NRXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$191K Buy
46,388
+11,909
+35% +$39.3K ﹤0.01% 1432
2026
Q1 		$102K Buy
34,479
+1,058
+3% +$2.14K ﹤0.01% 1390
2025
Q4 		$72.5K Sell
33,421
-8,573
-20% -$23K ﹤0.01% 1273
2025
Q3 		$126K Buy
+41,994
New +$120K ﹤0.01% 1183

Other funds holding NRXP

BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Chicago Partners Investment Group's NRXP Position: Q2 2026 in Review

Chicago Partners Investment Group increased its NRX Pharmaceuticals (NRXP) stake by 35% in Q2 2026, buying an estimated $39.3K and bringing the position to 46,388 shares worth $191K. The position accounts for ﹤0.01% of the portfolio, ranked #1432.

Chicago Partners Investment Group first reported a position in NRXP in Q3 2025 and has held it in 4 quarters since. 47 funds tracked by Wall St. Rank hold NRXP as of Q2 2026.

  • Chicago Partners Investment Group held 46,388 shares of NRX Pharmaceuticals worth $191K as of Q2 2026.
  • Chicago Partners Investment Group bought 11,909 NRX Pharmaceuticals shares in Q2 2026, an estimated $39.3K.
  • NRX Pharmaceuticals made up ﹤0.01% of Chicago Partners Investment Group's portfolio in Q2 2026, its #1432 holding.
  • Chicago Partners Investment Group first reported a position in NRX Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 47 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q2 2026.

Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.